SESN Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-28 | 2022 | Thomas R. Cannell, D.V.M Former President and Chief Executive Officer | 576,563 | 0 | 813,719 | 0 | 4,000 | 1,394,282 |
| 2023-04-28 | 2022 | Mark Sullivan Former General Counsel, Chief Compliance Officer and Corporate Secretary | 382,025 | 0 | 303,535 | 0 | 4,000 | 689,560 |
| 2023-04-28 | 2021 | Monica Forbes Former Chief Financial Officer and Treasurer | 380,750 | 0 | 148,778 | 145,447 | 4,000 | 1,874,640 |
| 2023-04-28 | 2022 | Monica Forbes Former Chief Financial Officer and Treasurer | 399,788 | 0 | 484,772 | 0 | 4,000 | 888,560 |
| 2023-04-28 | 2021 | Thomas R. Cannell, D.V.M Former President and Chief Executive Officer | 562,500 | 0 | 0 | 236,250 | 4,000 | 4,925,836 |
| 2022-04-28 | 2020 | Glen MacDonald, Ph.D. Chief Technology Officer | 343,714 | 1,000 | 0 | 160,917 | 14,067 | 674,731 |
| 2022-04-28 | 2021 | Glen MacDonald, Ph.D. Chief Technology Officer | 362,156 | 0 | 143,262 | 135,625 | 14,486 | 1,273,992 |
| 2022-04-28 | 2021 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 558,362 | 0 | 0 | 236,250 | 4,000 | 4,921,698 |
| 2022-04-28 | 2020 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 532,917 | 0 | 0 | 348,140 | 4,000 | 1,702,506 |
| 2022-04-28 | 2020 | Monica Forbes Chief Financial Officer and Treasurer | 360,500 | 1,000 | 0 | 174,500 | 0 | 795,329 |
| 2022-04-28 | 2021 | Monica Forbes Chief Financial Officer and Treasurer | 377,958 | 0 | 148,778 | 145,447 | 4,000 | 1,871,878 |
| 2021-03-25 | 2020 | Monica Forbes Chief Financial Officer and Treasurer | 360,500 | 1,000 | 0 | 174,500 | 0 | 795,329 |
| 2021-03-25 | 2019 | Glen MacDonald, Ph.D. Chief Technology Officer | 297,382 | 0 | 0 | 133,100 | 10,247 | 582,790 |
| 2021-03-25 | 2020 | Glen MacDonald, Ph.D. Chief Technology Officer | 343,714 | 1,000 | 0 | 160,917 | 14,067 | 674,731 |
| 2021-03-25 | 2020 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 532,917 | 0 | 0 | 348,140 | 4,000 | 1,702,506 |
| 2021-03-25 | 2019 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 520,000 | 0 | 0 | 312,000 | 4,000 | 1,404,244 |
| 2021-03-25 | 2019 | Monica Forbes Chief Financial Officer and Treasurer | 220,973 | 0 | 0 | 58,700 | 0 | 683,680 |
| 2020-03-30 | 2019 | Mark R. Sullivan General Counsel and Corporate Secretary | 456,949 | 0 | 0 | 140,875 | 4,000 | 937,718 |
| 2020-03-30 | 2019 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 520,000 | 0 | 0 | 312,000 | 4,000 | 1,404,244 |
| 2020-03-30 | 2018 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 198,012 | 0 | 0 | 97,500 | 280,000 | 2,009,874 |
| 2020-03-30 | 2019 | Monica Forbes Chief Financial Officer and Treasurer | 212,538 | 0 | 0 | 58,700 | 0 | 675,245 |
| 2019-04-30 | 2018 | Stephen A. Hurly Former President and Chief Executive Officer | 264,808 | 0 | 0 | 0 | 682,293 | 1,195,303 |
| 2019-04-30 | 2018 | Dennis Kim, M.D., MPH Chief Medical Officer | 24,235 | 0 | 0 | 0 | 0 | 513,196 |
| 2019-04-30 | 2017 | Richard F. Fitzgerald Chief Financial Officer, Secretary and Treasurer | 0 | 0 | 0 | 0 | 67,693 | 67,693 |
| 2019-04-30 | 2018 | Richard F. Fitzgerald Chief Financial Officer, Secretary and Treasurer | 294,412 | 0 | 0 | 87,967 | 19,693 | 664,520 |
| 2019-04-30 | 2017 | Stephen A. Hurly Former President and Chief Executive Officer | 425,000 | 116,802 | 0 | 0 | 4,000 | 1,067,329 |
| 2019-04-30 | 2018 | Thomas R. Cannell, D.V.M. President and Chief Executive Officer | 198,012 | 0 | 0 | 97,500 | 280,000 | 2,009,874 |
| 2018-04-30 | 2016 | Stephen A. Hurly President and Chief Executive Officer | 119,093 | 0 | 0 | 0 | 0 | 874,604 |
| 2018-04-30 | 2016 | John J. McCabe, C.P.A. Former Chief Financial Officer | 305,000 | 75,000 | 0 | 0 | 0 | 607,846 |
| 2018-04-30 | 2016 | Arthur DeCillis, M.D. Former Chief Medical Officer | 116,855 | 0 | 0 | 0 | 0 | 332,715 |
| 2018-04-30 | 2017 | Arthur DeCillis, M.D. Former Chief Medical Officer | 324,018 | 100,000 | 0 | 0 | 4,459 | 457,562 |
| 2018-04-30 | 2017 | Stephen A. Hurly President and Chief Executive Officer | 425,000 | 116,802 | 0 | 0 | 4,000 | 1,067,329 |
| 2018-04-30 | 2017 | John J. McCabe, C.P.A. Former Chief Financial Officer | 259,424 | 75,000 | 0 | 0 | 11,161 | 501,750 |
| 2018-04-30 | 2017 | Richard F. Fitzgerald | 0 | 0 | 0 | 0 | 67,693 | 67,693 |
| 2017-04-07 | 2016 | Karen Tubridy, Pharm.D. Former Chief Development Office | 233,889 | 0 | 0 | 0 | 323,710 | 582,251 |
| 2017-04-07 | 2016 | Stephen A. Hurly President and Chief Executive Officer | 119,093 | 0 | 0 | 0 | 0 | 874,604 |
| 2017-04-07 | 2015 | Stephen A. Hurly President and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-04-07 | 2016 | Abbie C. Celniker, Ph.D. Former President and Chief Executive Officer | 325,137 | 0 | 0 | 0 | 675,000 | 1,051,522 |
| 2017-04-07 | 2015 | Abbie C. Celniker, Ph.D. Former President and Chief Executive Officer | 430,000 | 150,500 | 236,722 | 0 | 4,000 | 1,798,120 |
| 2017-04-07 | 2016 | John J. McCabe, C.P.A. Chief Financial Officer | 305,000 | 75,000 | 0 | 0 | 0 | 607,846 |
| 2017-04-07 | 2015 | John J. McCabe, C.P.A. Chief Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-04-07 | 2016 | Arthur DeCillis, M.D. Chief Medical Officer | 116,855 | 0 | 0 | 0 | 0 | 332,715 |
| 2017-04-07 | 2015 | Arthur DeCillis, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017-04-07 | 2015 | Karen Tubridy, Pharm.D. Former Chief Development Office | 312,000 | 65,525 | 103,187 | 0 | 4,000 | 922,632 |
| 2016-04-29 | 2015 | Karen Tubridy, Pharm.D. | 312,000 | 65,525 | 103,187 | 0 | 4,000 | 922,632 |
| 2016-04-29 | 2014 | Eric S. Furfine, Ph.D. Chief Scientific Officer | 318,300 | 84,116 | 0 | 0 | 0 | 402,416 |
| 2016-04-29 | 2015 | Eric S. Furfine, Ph.D. Chief Scientific Officer | 327,849 | 65,405 | 108,429 | 0 | 4,000 | 859,388 |
| 2016-04-29 | 2014 | Abbie C. Celniker, Ph.D. President and Chief Executive Officer | 393,750 | 177,188 | 0 | 0 | 0 | 570,938 |
| 2016-04-29 | 2015 | Abbie C. Celniker, Ph.D. President and Chief Executive Officer | 430,000 | 150,500 | 236,722 | 0 | 4,000 | 1,798,120 |
| 2015-05-07 | 2014 | Gregory D. Perry. Chief Financial and Business Officer | 340,000 | 89,851 | 0 | 0 | 24,000 | 453,851 |
| 2015-05-07 | 2013 | Abbie C. Celniker, Ph.D. President and Chief Executive Officer | 375,000 | 84,375 | 0 | 0 | 0 | 732,747 |
| 2015-05-07 | 2014 | Abbie C. Celniker, Ph.D. President and Chief Executive Officer | 393,750 | 177,188 | 0 | 0 | 0 | 570,938 |
| 2015-05-07 | 2013 | Eric S. Furfine, Ph.D. Chief Scientific Officer | 309,000 | 35,500 | 0 | 0 | 0 | 436,376 |
| 2015-05-07 | 2014 | Eric S. Furfine, Ph.D. Chief Scientific Officer | 318,300 | 84,116 | 0 | 0 | 0 | 402,416 |
| 2015-05-07 | 2013 | Gregory D. Perry. Chief Financial and Business Officer | 3,923 | 0 | 0 | 0 | 0 | 905,485 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
